Cite
APA Citation
Dagogo-Jack, I., Oxnard, G. R., Evangelist, M., Digumarthy, S. R., Lin, J. J., Gainor, J. F., Murphy, J. F., Rabin, M. S., Heist, R. S., Muzikansky, A., & Shaw, A. T. (2022). phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase–Positive Lung Cancer and CNS-Specific Relapse. JCO precision oncology, 6, . http://access.bl.uk/ark:/81055/vdc_100156698832.0x000004